Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pro-active Genetic Testing in Kidney Transplant Patients
Sponsor: Mayo Clinic
Summary
The purpose of this study is to determine the prevalence of genetic mutations that increase the risk of cancer and other medically actionable diseases in kidney transplant patients and to assess the impact of genetic testing on subsequent surveillance for cancer.
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
177
Start Date
2022-03-28
Completion Date
2038-03-01
Last Updated
2026-01-27
Healthy Volunteers
No
Conditions
Interventions
Genetic Health Screen Panel
This panel covers cardiomyopathy genes, and cancer genes. The results of this panel are reported as Positive (pathogenic or likely pathogenic mutation identified in one or more genes) or Negative (no pathogenic/likely pathogenic mutations identified).
Locations (1)
Mayo Clinic Arizona
Scottsdale, Arizona, United States